This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Methotrexate associated photosensitivity

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Methotrexate associated photosensitivity

  • photosensitivity reactions are established side effects of methotrexate treatment and are currently listed in the product information, including the Patient Information Leaflet (1)

  • photosensitivity reactions often look and feel like sunburn
    • can leave sun-exposed skin with a rash, redness, swelling, blisters, red bumps or oozing lesions
    • severe cases can cause secondary skin infection
    • photosensitivity reactions fall into two categories
      • phototoxic reactions
        • a drug is activated by exposure to UV light and causes damage to the skin that can look and feel like a sunburn or a rash
        • reactions can happen within minutes or after hours of exposure and are usually limited to the skin that has been exposed
        • exposure to methotrexate and UV radiation can result in the typical phototoxic exaggerated sunburn response, characterized by erythema and oedema, and often accompanied by pain, tenderness, and pruritus (2)
          • blistering and desquamation may also occur in severe cases
          • the sites most frequently involved are sun-exposed areas on the face, chest, arms, and legs, as well as the dorsa of the hands and posterior region of the neck
          • hyperpigmentation is also common after the acute reaction has resolved, and may persist for several months (2)
      • photoallergic reactions
        • occur when UV rays interact with the ingredients in medicines or other products applied directly to the skin
        • the body's immune system recognizes changes caused by sun exposure as a foreign threat
        • body produces antibodies and attacks, causing a reaction
        • note that these reactions are distinct from "recall" reactions where radiation-induced dermatitis and sunburn can reappear on re-exposure to radiation and sunlight while on methotrexate therapy
          • UV recall is an exceptional inflammatory phototoxic reaction that occurs after administration of a systemic therapy and strictly affects areas of skin that have been involved in a prior episode of UV-induced solar erythema (2)

Advice for healthcare professionals (1):

  • photosensitivity reactions (which include phototoxicity, where a drug is activated by exposure to UV light and causes damage to the skin that can look and feel like a sunburn or a rash) are known side effects of methotrexate treatment and can occur with both low-dose and high-dose treatment
  • reactions manifest as severe sunburn such as rashes with papules or blistering, with some patients reporting swelling; rarely, photosensitivity reactions have contributed to deaths from secondary infections
  • healthcare professionals, including those prescribing and dispensing methotrexate, should remind patients to take precautions to protect themselves from the sun and UV rays
  • report suspected adverse drug reactions associated with methotrexate on a Yellow Card

Reference:

  • Drug Safety Update volume 17, issue 1: August 2023: 2.
  • Sibaud V. Anticancer treatments and photosensitivity. J Eur Acad Dermatol Venereol. 2022 Jun;36 Suppl 6(Suppl 6):51-58. doi: 10.1111/jdv.18200. PMID: 35738806; PMCID: PMC9328141

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.